QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.103.056036v1 308/1/358    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Abo-Salem, O. M. Articles by Müller, C. E. Search for Related Content PubMed PubMed Citation Articles by Abo-Salem, O. M. Articles by Müller, C. E.

BEHAVIORAL PHARMACOLOGY

Antinociceptive Effects of Novel A_2B Adenosine Receptor Antagonists

Laboratory of Molecular Neurobiology, Department of Psychiatry, University of Bonn, Bonn, Germany (O.M.A.-S., A.B.-G., A.Z.); Pharmaceutical Institute, Department of Pharmaceutical Chemistry Poppelsdorf, University of Bonn, Bonn, Germany (A.M.H., C.E.M.); and Laboratory of Pharmacological Screening, Collegium Medicum, Jagiellonian University, Krakow, Poland (B.F.)

Caffeine, an adenosine A₁, A_2A, and A_2B receptor antagonist, is frequently used as an adjuvant analgesic in combination with nonsteroidal anti-inflammatory drugs or opioids. In this study, we have examined the effects of novel specific adenosine receptor antagonists in an acute animal model of nociception. Several A_2B-selective compounds showed antinociceptive effects in the hot-plate test. In contrast, A₁- and A_2A-selective compounds did not alter pain thresholds, and an A₃ adenosine receptor antagonist produced thermal hyperalgesia. Evaluation of psychostimulant effects of these compounds in the open field showed only small effects of some antagonists at high doses. Coadministration of low, subeffective doses of A_2B-selective antagonists with a low dose of morphine enhanced the efficacy of morphine. Our results indicate that analgesic effects of caffeine are mediated, at least in part, by A_2B adenosine receptors.

Address correspondence to: Dr. Andreas Zimmer, Laboratory of Molecular Neurobiology, Department of Psychiatry, Sigmund-Freud-Str. 25, D-53105 Bonn, Germany. E-mail: neuro{at}uni-bonn.de

This article has been cited by other articles:

				S. Gessi, K. Varani, S. Merighi, E. Cattabriga, C. Pancaldi, Y. Szabadkai, R. Rizzuto, K.-N. Klotz, E. Leung, S. Mac Lennan, et al. Expression, Pharmacological Profile, and Functional Coupling of A2B Receptors in a Recombinant System and in Peripheral Blood Cells Using a Novel Selective Antagonist Radioligand, [3H]MRE 2029-F20 Mol. Pharmacol., June 1, 2005; 67(6): 2137 - 2147. [Abstract] [Full Text] [PDF]